IGMPI facebook News
IGMPI Logo
Faculty of Pharmaceutical Sciences

(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)

ADMISSIONS NOTICE
18001031071 (Toll Free), +91 11 26512850
Regular Classroom | Online Mode
Experts warn: EPA rollbacks could endanger public health
Experts warn: EPA rollbacks could endanger public health
New Dietary Fiber Classification for Better Health Outcomes
New Dietary Fiber Classification for Better Health Outcomes
Tata Soulfull Launches ‘No Maida Rusk’ to Redefine Chai-Time Rituals
Tata Soulfull Launches ‘No Maida Rusk’ to Redefine Chai-Time Rituals
Protinex Launches Affordable Sachet Range to Tackle India’s Protein Deficiency
Protinex Launches Affordable Sachet Range to Tackle India’s Protein Deficiency
Legends Haul Recalls Chicken Pesto Parm Sausage Due to Undeclared Wheat
Legends Haul Recalls Chicken Pesto Parm Sausage Due to Undeclared Wheat
WHO Alert: Falsified Oxycontin 80mg Found in Switzerland
WHO Alert: Falsified Oxycontin 80mg Found in Switzerland
FDA Issues Early Alert for Calyxo’s CVAC Aspiration System
FDA Issues Early Alert for Calyxo’s CVAC Aspiration System
Newsom stalls California’s strict plastic waste rules following industry pushback
Newsom stalls California’s strict plastic waste rules following industry pushback
Decades of pesticide use in the French Caribbean associated with high prostate cancer rates
Decades of pesticide use in the French Caribbean associated with high prostate cancer rates
Doctors Warn of Severe Health Risks from Counterfeit and Substandard Medicines
Doctors Warn of Severe Health Risks from Counterfeit and Substandard Medicines
IIIT Hyderabad launches Centre for Digital Technologies in Healthcare focusing on AI treatment
IIIT Hyderabad launches Centre for Digital Technologies in Healthcare focusing on AI treatment
FDA Issues Warning Letter to Chinese Manufacturer Over CGMP Violations
FDA Issues Warning Letter to Chinese Manufacturer Over CGMP Violations
Opthia could owe $1bn to investors following sozinibercept trial failure
Opthia could owe $1bn to investors following sozinibercept trial failure
OmniActive’s Muvz Clinically Proven to Support Joint & Mobility Health
OmniActive’s Muvz Clinically Proven to Support Joint & Mobility Health
FDA Classifies BD Infusion Pump Software Recall as Class I
FDA Classifies BD Infusion Pump Software Recall as Class I